Noida 201301 (INDIA)
Mon - Sat : 09.00 AM - 09.00 PM
18001200365

Core Services

RLD & Comparator Drug Sourcing Services in India | FDA & EMA Compliant

Accurate Comparator Selection. Regulatory Precision. Study-Ready Supply.
Ikris Pharma Network provides specialized RLD sourcing services in India, supporting pharmaceutical companies, CROs, and research organizations in sourcing Reference Listed Drugs (RLDs) and comparator drugs from regulated markets, including the US, EU, UK, and Japan.
With over a decade of experience in clinical trial comparator sourcing in India, BA/BE studies, and regulatory-aligned procurement, we understand that comparator selection is not just procurement — it is a regulatory decision that directly impacts study outcomes, approval timelines, and compliance.

What is RLD & Comparator Drug Sourcing?

RLD sourcing involves procuring Reference Listed Drugs (RLDs) or comparator products from regulated markets for use in:

  • Bioequivalence (BA/BE) studies
  • Phase I–IV clinical trials
  • Formulation development and R&D

The selected RLD must align with:

  • FDA Orange Book listings (US)
  • EMA reference products (EU)
  • MHRA-approved products (UK)

Incorrect comparator selection can result in study failure, regulatory rejection, or delayed approvals.

Why RLD Sourcing is Critical?

In real-world clinical and regulatory scenarios, we frequently see:

  • Market Mismatch: Using a US RLD where an EU comparator is required can lead to non-acceptance by regulatory authorities
  • Batch Inconsistency: Sourcing different batches across study phases can impact bioequivalence outcomes
  • Documentation Gaps: Missing COA or incomplete pedigree records can cause import delays and compliance issues
  • Cold-Chain Failure: Temperature excursions during transit can compromise product integrity and study validity

These are not theoretical risks — they are common causes of study delays and rejection.

Our RLD & Comparator Drug Sourcing Capabilities

Global Sourcing from Regulated Markets

  • US (FDA Orange Book-listed products)
  • Europe (EMA-approved reference products)
  • UK (MHRA-approved drugs)
  • Japan and other regulated markets

Study-Aligned Comparator Selection

  • Innovator vs reference product identification
  • Market-specific comparator alignment
  • Regulatory guidance for protocol compliance

Batch-Specific & Protocol-Driven Sourcing

  • Same batch procurement for study consistency
  • Multi-strength sourcing
  • Matching dosage form and formulation

Verified Supply Chain

  • Authorized distributors only
  • Direct sourcing from regulated markets
  • Full product authenticity assurance

Regulatory-Ready Documentation

Every shipment is supported with:

  • Certificate of Analysis (COA)
  • Certificate of Origin (COO) (if required)
  • Commercial Invoice & Packing List
  • Batch traceability and pedigree records
  • Product labels and regulatory reference documentation

Ensuring smooth import clearance and regulatory acceptance.

How to Choose the Right RLD?

Selecting the correct RLD requires:

  • Regulatory Alignment: Match the comparator with the target regulatory authority (USFDA, EMA, MHRA)
  • Market of Approval: Choose the correct reference market for submission
  • Batch Consistency: Ensure the same batch across study phases
  • Product Integrity: Maintain cold-chain and storage compliance

A wrong decision here can delay your approval by months.

Who We Support

Our comparator drug sourcing services in India are trusted by:

  • Pharmaceutical companies
  • CROs and clinical research organizations
  • Regulatory and R&D teams
  • Drug development companies

Integrated Logistics & Cold Chain Expertise

We ensure:

  • GDP-compliant cold chain logistics
  • Real-time temperature monitoring
  • Validated packaging systems
  • Secure international shipping

Especially critical for biologics and temperature-sensitive RLDs.

When You Need RLD & Comparator Sourcing

We support:

  • BA/BE studies
  • Phase I–IV clinical trials
  • Formulation development
  • Regulatory submissions
  • Multi-country sourcing strategies

How RLD & Comparator Drug Sourcing Works?

1. Share Study Requirements: Molecule, strength, reference market (US/EU/UK), batch preference, and quantity

2. Comparator Identification & Verification: Selection aligned with FDA Orange Book / EMA reference product requirements

3. Availability & Quotation (Within 24 Hours): Verified sourcing from regulated markets with batch-specific details

4. Regulatory Documentation Review: COA, pedigree, and compliance documentation prepared for import and study use

5. Secure Cold-Chain Delivery: Temperature-controlled shipment ensuring product integrity and study readiness

Why Choose Ikris Pharma Network for RLD & Comparator Drug Sourcing in India?

  • 12+ years of hands-on experience in RLD sourcing and comparator selection in India
  • Deep expertise in clinical trial supply, BA/BE studies, and protocol-aligned sourcing
  • Access to a global network of authorized distributors across the US, EU, UK, and Japan
  • Strong understanding of FDA, EMA, and MHRA expectations for comparator selection
  • GDP-compliant cold-chain logistics ensuring product integrity from source to site
  • Experience in mitigating common sourcing risks such as batch mismatch, documentation gaps, and temperature excursions

We don't just source medicines — we help ensure regulatory acceptance and study continuity.

Get Verified RLD Availability Within 24 Hours

Avoid costly delays and ensure correct comparator selection from Day 1. Get pricing, availability, and documentation support within 24 hours.

Frequently Asked Questions (FAQs)

RLD sourcing services involve procuring Reference Listed Drugs from regulated markets such as the US, EU, and UK for use in clinical trials, BA/BE studies, and drug development.
Comparator drugs can be sourced through specialized suppliers like Ikris Pharma Network, ensuring regulatory compliance, documentation, and temperature-controlled delivery.
Incorrect comparator selection can lead to regulatory rejection, inaccurate study results, and delays in drug approval.
Clinical trial comparator sourcing in India involves procuring reference drugs from regulated markets. Ikris Pharma Network supports compliant sourcing, documentation, and temperature-controlled delivery for clinical studies.
A reliable RLD supplier in India ensures authentic sourcing from authorized distributors. Ikris Pharma Network provides compliant procurement, documentation support, and verified comparator supply for clinical and research use.
Reference listed drug procurement in India involves identifying correct comparators, sourcing from regulated markets, and ensuring documentation. Ikris Pharma Network manages end-to-end sourcing, compliance, and delivery.
BA/BE comparator sourcing in India involves procuring reference drugs for bioequivalence studies. Ikris Pharma Network supports batch-specific sourcing, regulatory documentation, and timely delivery aligned with study requirements.
Availability and pricing are typically confirmed within 24 hours, while delivery timelines depend on sourcing location and logistics.

Get in Touch with Our Team

Looking for a reliable partner for pharmaceutical exports from India or Reference Listed Drug (RLD) services? Ikris Pharma Network combines regulatory expertise, verified sourcing, and a precision-driven supply process to meet your requirements with confidence.

Submit your requirement today and receive a prompt response from our specialists.

Call Us Now: 18001200365

Mail Us Now

info@ikrispharmanetwork.in

Office Address

905, I-Thum Business Park, Plot No. A-40, Unit No. 5, Tower A, Sector-62, Noida – 201301 (India)